Assembly Actions -
Senate Actions - UPPERCASE
|May 01, 2018
held for consideration in health
|Jan 03, 2018
referred to health
|Feb 03, 2017
referred to health
Assembly Bill A4562
2017-2018 Legislative Session
Archive: Last Bill Status - In Assembly Committee
- In Committee Assembly
- On Floor Calendar Assembly
- Passed Assembly
- Delivered to Governor
- Signed By Governor
2017-A4562 (ACTIVE) - Details
2017-A4562 (ACTIVE) - Summary
Enacts the New York state pharmaceutical drug manufacturer and wholesaler disclosure act; requires pharmaceutical drug manufacturers and wholesalers to annually report to the New York department of health, for disclosure to the general public, all of its gifts to health care practitioners that prescribe drugs when such gifts have a value of seventy-five dollars or more; authorizes the commissioner of health to impose penalties and promulgate necessary rules and regulations.
2017-A4562 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 4562 2017-2018 Regular Sessions I N A S S E M B L Y February 3, 2017 ___________ Introduced by M. of A. DiPIETRO -- read once and referred to the Commit- tee on Health AN ACT to amend the public health law, in relation to disclosure of certain gifts provided by drug manufacturers or wholesalers to health care providers THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Article 2 of the public health law is amended by adding a new title 7 to read as follows: TITLE VII NEW YORK STATE PHARMACEUTICAL DRUG MANUFACTURER AND WHOLESALER DISCLOSURE ACT SECTION 267. LEGISLATIVE INTENT. 267-A. DEFINITIONS. 267-B. DISCLOSURE REQUIREMENTS. 267-C. ANNUAL CONSUMER GUIDE ON PHARMACEUTICAL DRUG MANUFACTURER AND WHOLESALER GIFTS TO HEALTH CARE PROVIDERS. 267-D. PENALTIES. 267-E. RULES AND REGULATIONS. § 267. LEGISLATIVE INTENT. THE LEGISLATURE FINDS THAT THE COST OF PRESCRIPTION DRUGS IN THE UNITED STATES HAS GROWN DRAMATICALLY. ACCORD- ING TO THE CENTERS FOR DISEASE CONTROL, SPENDING ON RETAIL PRESCRIPTION DRUGS IN THE UNITED STATES MORE THAN TRIPLED FROM FIFTEEN BILLION DOLLARS IN NINETEEN HUNDRED EIGHTY-TWO TO FORTY-EIGHT BILLION TWO HUNDRED MILLION DOLLARS IN NINETEEN HUNDRED NINETY-TWO, THEN MORE THAN TRIPLED AGAIN TO ONE HUNDRED SIXTY-TWO BILLION FOUR HUNDRED MILLION DOLLARS IN TWO THOUSAND TWO. IN PER CAPITA TERMS, RETAIL PRESCRIPTION DRUGS SPENDING INCREASED FROM SIXTY-FOUR DOLLARS IN NINETEEN HUNDRED EIGHTY-TWO TO FIVE HUNDRED SIXTY-NINE DOLLARS IN TWO THOUSAND TWO. IN TWO THOUSAND FIVE, SPENDING ON PHARMACEUTICALS ROSE TO TWO HUNDRED EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.